Use of peptides derived from the growth factor amp-18 for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61P 1/02 (2006.01)

Patent

CA 2643736

Methods and compositions of AMP- 18 derived peptides enablingly demonstrate that AMP-18 derived peptide compositions surprisingly reduce mucositis in mammals. Methods and peptide compositions treat mucositis, delays the onset or duration of mucositis, including cancer therapy-induced mucositis are disclosed. AMP 77-97 peptide derived from human AMP-18 protein alleviates cancer therapy-induced mucositis.

La présente invention concerne des procédés et des compositions à base de peptides dérivés d'AMP-18, qui font la preuve de façon validante que les compositions à base de peptides dérivés d'AMP-18 atténuent de façon surprenante la mucosite chez les mammifères. L'invention concerne notamment des procédés et des compositions qui traitent la mucosite, qui retardent la survenue ou la durée de la mucosite, y-compris les mucosites induites par les thérapies anticancéreuses. Les peptides AMP 77-97 dérivés de la protéine AMP-18 humaine atténuent les mucosites induites par les thérapies anticancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of peptides derived from the growth factor amp-18 for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of peptides derived from the growth factor amp-18 for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peptides derived from the growth factor amp-18 for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1828249

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.